GlassScriptPhysician profile
Seth Jacob Bricel
NPI 1437543410
$1,627.65
in general payments reported to CMS, 2019-2025
14 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $68.92 · 2023: $454 · 2024: $632 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $472.95 | 2023-2025 | Durysta |
| Alcon Vision LLC | $464.98 | 2022-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Glaukos Corporation | $156.71 | 2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $135.89 | 2024 | Omni Surgical System |
| Apellis Pharmaceuticals, INC. | $117.94 | 2023 | |
| Rxsight INC | $77.63 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $44.93 | 2022-2023 | Tyrvaya |
| Thea Pharma INC. | $41.74 | 2023-2025 | Iyuzeh |
| Carl Zeiss Meditec USA, INC. | $28.54 | 2025 | Cirrus Hd-Oct |
| Biotissue Holdings INC. | $23.61 | 2023 | |
| Harrow Eye, LLC | $20.70 | 2023 | Iheezo |
| New World Medical,INC. | $16.08 | 2023 | |
| Allergan, INC. | $13.22 | 2022 | |
| Bausch & Lomb Americas INC. | $12.73 | 2023 | Vyzulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Bricel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.